9% voltage after 24 h at 100 mA cm-2.Enabling materials with distinct features toward achieving high-performance energy storage devices is of huge importance but highly challenging. Commercial carbon cloth (CC), because of its appealing chemical and mechanical properties, has been proven to be an excellent conductive substrate for active electrode materials. However, its performance is notably poor when directly used as an electrode in energy storage, due to its low theoretical capacity and surface area. Herein, we successfully endow the CC with enhanced storage capacity via formation of a π-π stacking interaction by integrating electrochemically activated CC (denoted CC/ACC) with biomass-derived carbon (BMDC) (denoted π-CC/ECC@BMDC). The π-CC/ECC@BMDC electrode displays excellent storage performance with a high capacity of 2.53 mAh cm-2 under 0.2 mA cm-2 when used as anode material for lithium ion batteries (LIBs). Due to the induction energy, the negatively charged molecules of the CC/ACC functional groups interact with the BMDC during carbonization, creating the π-π stacking interaction. Based on first-principles calculations, the structural design of the tri-layer carbon enables the movement of electrons around the π-π stacking interaction, which significantly facilitates rapid transportation of electrons, creates three-dimensional (3D) ion tunnels for fast transportation of ions, and improves the electrode's mechanical and electronic properties.As the toll of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic continues, efforts are ongoing to identify new agents and repurpose safe drugs for its treatment. Antimalarial peroxides have reported antiviral and anticancer activities. Here, we evaluated the in vitro activities of artesunate (AS) and two ozonides (OZ418 and OZ277) against human α-coronavirus NL63 and β-coronaviruses OC43 and SARS-CoV-2 in several cell lines. OZ418 had the best selectivity index (SI) in NL63-infected Vero cells and MK2 cells. https://www.selleckchem.com/products/nik-smi1.html The overall SI of the tested compounds was cell-type dependent. In OC43-infected human foreskin fibroblasts, AS had the best cell-associated SI, ≥17 μM, while the SI of OZ418 and OZ277 was ≥12 μM and ≥7 μM, respectively. AS did not inhibit SARS-CoV-2 in either Vero or Calu-3 cells. A comparison of OZ418 and OZ277 activity in SARS-CoV2-infected Calu-3 cells revealed similar EC50 (5.3 μM and 11.6 μM, respectively), higher than the EC50 of remdesivir (1.0 ± 0.1 μM), but the SI of OZ418 was higher than OZ277. A third ozonide, OZ439, inhibited SARS-CoV-2 efficiently in Vero cells, but compared to OZ418 in Calu-3 cells, it showed higher toxicity. Improved inhibition of SARS-CoV-2 was observed when OZ418 was used together with remdesivir. Although the EC50 of ozonides might be clinically achieved in plasma after intravenous administration, sustained virus suppression in tissues will require further considerations, including drug combination. Our work supports the potential repurposing of ozonides and calls for future in vivo models.Artificial photofunctional systems with energy and electron transfer functions, inspired from photosynthesis in nature, have been developed for many promising applications including solar cell, biolabeling, photoelectric materials, and photodriven catalysis. Supramolecular hosts including macrocycles and cages have been explored for simulating photosynthesis based on a host-guest strategy. Herein, we report a host-guest approach by using a tetraphenylethene-based octacationic cage and fluorescent dyes to construct artificial photofunctional systems with energy and electron transfer functions. The cage traps various dyes within its hydrophobic cavity to form 11 host-guest complexes via CH-π, π-π, and/or electrostatic interactions in solution. The efficient energy transfer and ultrafast photoinduced electron transfer between the cage and dyes are competitive processes with each other in artificial photofunctional systems. Spectroscopic techniques that confirm energy transfer from the fluorescent cage to dyes (e.g., NiR, R700, and R800) are efficient, which induce the red shift of fluorescence. On the other hand, ultrafast photoinduced electron transfer from dyes (e.g., ICG, AG, and AV) to the fluorescent cage can induce fluorescence quenching. This study provides an insight into the construction of artificial photofunctional systems with energy and electron transfer functions via a host-guest approach in solution. The aim of this study was to evaluate the performance of a comprehensive diagnosis program called "Reuma-check" for the diagnosis of axial spondyloarthritis (SpA) in patients with low back pain (LBP). This is a cross-sectional study. Patients with LBP aged 18 years or older were preselected, and those with at least 1 SpA feature completed the circuit. They were referred after 2 strategies education for orthopedists and a campaign on social networks. All patients underwent a clinical evaluation, laboratory testing, and imaging (including human leukocyte antigen B27 evaluation and magnetic resonance imaging). The diagnosis of axial SpA was established by an expert rheumatologist opinion. Time from onset of symptoms to "Reuma-check," time from patient referral to admission of the checkup, and time from "Reuma-check" to diagnosis were evaluated. A total of 175 of 246 patients were included, most of them came from the social media campaign (55%). Seventy-five (43%) of 175 patients were diagnosed as axial SpAosis with a shorter acquisition time for the ancillary studies. Patients with a final diagnosis of axial SpA presented distinctive features.X-linked hypophosphatemia (XLH) is a rare genetic disorder with x-linked dominant inheritance. The mutation on the PHEX gene increases fibroblast growth factor 23 (FGF23), causing loss of phosphorus at the proximal tubule. Most pediatric patients debut in the first two years with short stature and bow legs. Conventional treatment consists of oral supplements with phosphorus and calcitriol. Since 2018, burosumab is approved as a novel therapeutic option for XLH with promising results. The purpose of this study is to share our experience with two cases of XLH treated with burosumab. These patients presented with a broad phenotypical difference - the one with the most severe radiological phenotype developed left ventricular hypertrophy and left ventricular dysfunction with preserved ejection fraction. Treatment with burosumab was well-tolerated and was followed by radiological stability and a striking improvement in both patients' biochemistry and quality of life. The left ventricular hypertrophy was stabilized and left ventricular function normalized in the patient with cardiac involvement.